The CB1 subtype of the cannabinoid receptor is present on neurons in the brain and mediates the perceptual effects of ⁹-tetrahydrocannabinol and other cannabinoids. We found that cat cerebral arterial smooth muscle cells (VSMC) contain the protein for the CB1 receptor and express a cDNA that has >98% amino acid homology to the CB1 cDNA expressed in rat and human neurons. Activation of the CB1 cannabinoid receptor has been shown to decrease the opening of N-type voltage-gated Ca²⁺ channels in neurons through a pertussis toxin-sensitive GTP-binding protein. In the present study we tested the hypothesis that activation of the cannabinoid CB1 receptor in cerebral VSMC inhibits voltage-gated Ca²⁺ channels and results in cerebral vasodilation. The predominant Ca²⁺ current identified in cat cerebral VSMC is a voltage-gated, dihydropyridine-sensitive, L-type Ca²⁺ current. The cannabimimetic drug WIN-55,212-2 (10-100 nM) induced concentration-dependent inhibition of peak L-type Ca²⁺ current, which reached a maximum of 82 ± 4% at 100 nM (n = 14). This effect was mimicked by the putative endogenous CB1-receptor agonist anandamide, which produced a concentration-related reduction of peak L-type Ca²⁺ current with a maximum inhibition (at 300 nM) of 39 ± 4% (n = 12). The inhibitory effects of both ligands on peak L-type Ca²⁺ currents were abolished by pertussis toxin pretreatment and application of the CB1-receptor antagonist SR-141716A (100 nM, n = 5). Both WIN-55,212-2 and anandamide produced concentration-dependent relaxation of preconstricted cerebral arterial segments that was abolished by SR-141716A. These results indicate that the CB1 receptor is expressed in cat cerebral VSMC and that the cerebral vasculature is one of the targets for endogenous cannabinoids. These findings suggest that the CB1 receptor and its endogenous ligand may play a fundamental role in the regulation of cerebral arterial tone and reactivity by modulating the influx of Ca²⁺ through L-type Ca²⁺ channels.

anandamide; WIN-55,2121-2; SR-141716A; whole cell; patch clamp; vasodilation

This article has been cited by other articles:

				S. Batkai, P. Mukhopadhyay, J. Harvey-White, R. Kechrid, P. Pacher, and G. Kunos Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1689 - H1695. [Abstract] [Full Text] [PDF]

				S. Batkai, M. Rajesh, P. Mukhopadhyay, G. Hasko, L. Liaudet, B. F. Cravatt, A. Csiszar, Z. Ungvari, and P. Pacher Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H909 - H918. [Abstract] [Full Text] [PDF]

				H. Wahn, J. Wolf, F. Kram, S. Frantz, and J. A. Wagner The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2491 - H2496. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, D. Osei-Hyiaman, L. Offertaler, J. Liu, J. Harvey-White, A. Brassai, Z. Jarai, B. F. Cravatt, and G. Kunos Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H533 - H541. [Abstract] [Full Text] [PDF]

				D. J. Rademacher, S. Patel, W.-S. V. Ho, A. M. Savoie, N. J. Rusch, K. M. Gauthier, and C. J. Hillard U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2694 - H2701. [Abstract] [Full Text] [PDF]

				S. Batkai, P. Pacher, Z. Jarai, J. A. Wagner, and G. Kunos Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H595 - H600. [Abstract] [Full Text] [PDF]

				A. Straiker and J. M. Sullivan Cannabinoid Receptor Activation Differentially Modulates Ion Channels in Photoreceptors of the Tiger Salamander J Neurophysiol, May 1, 2003; 89(5): 2647 - 2654. [Abstract] [Full Text] [PDF]

				Y. Chen, R. M. McCarron, Y. Ohara, J. Bembry, N. Azzam, F. A. Lenz, E. Shohami, R. Mechoulam, and M. Spatz Human Brain Capillary Endothelium : 2-Arachidonoglycerol (Endocannabinoid) Interacts With Endothelin-1 Circ. Res., August 18, 2000; 87(4): 323 - 327. [Abstract] [Full Text] [PDF]

				C. J. Hillard Endocannabinoids and Vascular Function J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 27 - 32. [Abstract] [Full Text]

				Z. Jarai, J. A. Wagner, S. K. Goparaju, L. Wang, R. K. Razdan, T. Sugiura, A. M. Zimmer, T. I. Bonner, A. Zimmer, and G. Kunos Cardiovascular Effects of 2-Arachidonoyl Glycerol in Anesthetized Mice Hypertension, February 1, 2000; 35(2): 679 - 684. [Abstract] [Full Text] [PDF]